ARLINGTON, Va., Dec. 1 /PRNewswire/ -- BioInformatics, LLC announces the release of its newest report, The Market Outlook for Research Products in FY2010. The 8.2 billion dollars appropriated to the NIH Scientific Research program by the American Recovery and Reinvestment Act (ARRA) is being earmarked for lab renovations, Challenge Grants, the Shared Instrumentation Program and research that spans multiple public and non-profit institutions, all of which will have an immediate and long-term impact on the life science tools industry. Comprised of responses from scientists with varying degrees of influence and purchasing authority in the lab, The Market Outlook for Research Products in FY2010 was designed to help provide insight as to how labs are going to allocate their budgets over the next fiscal year, how they are responding to the economic recession and where they believe their organizations are headed in FY2011.
The Market Outlook for Research Products in FY2010, includes detailed responses from nearly 800 scientists about their FY2010 budgets, planned expenditures and sources of funding. This study compares and contrasts FY2009 (actual) and FY2010 (projected) budgets in total, and by product category with a special focus on market segment and regional differences. European and U.S. scientists are asked about planned purchases of both consumables and instrumentation, and from what sources they expect to receive funding, with an emphasis on the ARRA. 61% of the survey respondents said that either they or someone in their lab applied for a recovery act grant.
Abcam
Abgene (Thermo Fisher Scientific )
Affymetrix (NasdaqGS: AFFX)
Agilent Technologies
BD Biosciences
Bio-Rad
Beckman Coulter
BioSource (Life Technologies (NasdaqGS: LIFE))
Calbiochem
Millipore
Dako
GE Healthcare (Amersham)
Invitrogen
Leica Microsystems
PerkinElmer
Qiagen (NasdaqGS: QGEN)
Roche Applied Science
Sigma-Aldrich
Waters Corporation
To learn more about this report, a complimentary Executive Summary is available at http://www.gene2drug.com/reports/205/.
ABOUT BIOINFORMATICS, LLC
BioInformatics, LLC
